Ireland· IE-PA-EU/1/24/1897/001
Emcitate 350 microgram dispersible tablets
A tiratricol product containing tiratricol, registered in Ireland by Rare Thyroid Therapeutics International AB. The same ATC class is registered in 10 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Tiratricol is registered in 10 of 19 countries.
Countries holding a registration under ATC H03AA04 (tiratricol), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Tiratricol · ATC H03AA04
10 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- United Kingdom
The record
At a glance
HPRA (Ireland)- Active substance
- Tiratricol
- Manufacturer
- Rare Thyroid Therapeutics International AB
- Country
- Ireland (IE)
- ATC code
- H03AA04
- ATC class
- Tiratricol
- Defined daily dose
- 1.75 mg, O
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/24/1897/001
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Tiratricol in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumEmcitate 350 µgRare Thyroid Therapeutics International
- SpainEMCITATE 350 MICROGRAMOS COMPRIMIDOS DISPERSABLESRare Thyroid Therapeutics International Ab
- FinlandEmcitateRare Thyroid Therapeutics International AB
- NetherlandsEmcitate 350 microgram dispergeerbare tablettenRare Thyroid Therapeutics International AB
- NorwayEmcitateRare Thyroid Therapeutics
- PolandEmcitateRare Thyroid Therapeutics International AB
- SwedenEmcitate 350 mikrogram Dispergerbar tablettRare Thyroid Therapeutics International AB
- CzechiaEMCITATERare Thyroid Therapeutics International AB, Stockholm
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Emcitate
- Liechtenstein · Emcitate
- Norway · Emcitate
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bac580fe-a2c1-4cee-a081-320d63ddf5d0 GET /v1/drugs/bac580fe-a2c1-4cee-a081-320d63ddf5d0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Dispersible tablet",
"routes": [
"Oral use"
],
"source": "hpra",
"atc_all": [
"H03AA04"
],
"strength": null,
"pa_number": "EU/1/24/1897/001",
"substances": [
"Tiratricol"
],
"legal_basis": "Generic application (Article 10(1) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "12/02/2025",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about tiratricol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.